Click here for more information about laboratory operations and procedures
If you have additional questions regarding this test, please call: 415-353-1667
Hemophilia A Inversion
|Utilization Guidelines||Tests with long turn-around times (ie. Molecular based tests and Microarrays) should only be requested on an inpatient if the result is going to affect the inpatient management.
If the patient will likely be discharged before the result will be available, the test should be requested after discharge. (NOTE: UCSF Medical Center is not reimbursed for inpatient testing).
An exception to the above may be appropriate if there is a possibility the patient will not survive to be discharged and the information is important for diagnosis and/or family decisions/management (ie. recurrence risk).
|Performed by||Medical Genomics - Molecular Diagnostics|
|In House Availability||Run 1x per week as needed, Wednesday or Friday, day shift only|
|Collection Instructions||If collecting in citrate, check the expiration date on the label of the blue top vacutainer before drawing the patient.
Do not collect sample in heparin. Keep sample refrigerated for overnight or longer storage.
For UCSF Samples (from remote sites) Click here for sample collection instructions
For NON-UCSF Samples Click here for Requisition form & Account set-up instructions. Note we only do institutional billing.
|Container type||Lavender top , [Blue (citrate) and Yellow (ACD) tops acceptable]|
|Amount to Collect||3 mL blood|
|Sample type||Whole blood, CVS, Tissue culture|
|Preferred volume||3 mL blood|
|Min. Volume||0.2 mL blood|
|UCSF Rejection Criteria||Samples collected in outdated blue top vacutainer.|
|Processing notes||Do not centrifuge the specimen. Store at room temperature. Refrigerated samples are acceptable|
|Turn around times||10-14 days|
|Additional information||An interpretation of this test by a laboratory physician will automatically be performed and billed for separately.
This mutation is the single most common abnormality found in Hemophilia A, is responsible for approximately 50% of the most severe cases, and is present in about 25% of all cases.
If a mutation is detected it is recommended that the patient seek genetic counseling.
Note: This test was developed and its performance characteristics determined by the Clinical Laboratories at the Medical Center at UC San Francisco. It has not been cleared or approved by the U.S. Food and Drug Administration
|LDT or Mod FDA?||Yes|
|Last Updated||1/22/2014 8:59:46 AM|